After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Trade-Ideas LLC identified Seattle Genetics (SGEN) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Here are Wednesday's top research calls, including upgrades for Coach and Alaska Air, and downgrades for Southwest Airlines and Twitter.
Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.
Biotech stocks remain pressured following the recent Brexit vote, which will make investing in these already highly volatile stocks even trickier. But there are opportunities too.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.